Clinical Trial Update: Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+ [NA]

View source ↗

Summary

A clinical trial update comparing visual acuity outcomes between the Alcon Vivity Toric intraocular lens and the RxSight LAL+ lens in cataract patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Alcon Vivity Toric IOL
• RxSight LAL+

Snippet

Sponsor: The Eye Associates | Conditions: Cataract | NA | Status: NOT_YET_RECRUITING